Phase 1 Trial of Interleukin 12 Gene Therapy for Metastatic Pancreatic Cancer
Clinical trial NCT03281382 · COMPLETED
Trial details
- NCT number
- NCT03281382
- Sponsor
- Henry Ford Health System
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-01
- Primary completion
- 2019-05-28
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.